Update on Ischemia-reperfusion Injury for the Plastic Surgeon: 2011

Overview

Journal Plast Reconstr Surg

Specialty General Surgery

Date 2011 Nov 19

PMID 22094770

Citations 50

Authors

Wei Z Wang

Richard C Baynosa

William A Zamboni

Affiliations

Soon will be listed here.

Abstract

Ischemia-reperfusion injury occurs when tissue is reperfused following a prolonged period of ischemia. It is a subject of interest to plastic surgeons involved in replantation, free tissue transfer, and composite tissue allotransplantation, as it can have a significant impact on the overall success of these procedures. The purpose of this article is to review the recent progress in the investigation of ischemia-reperfusion injury in skeletal muscle and skin and to highlight the potential clinical implications of therapeutic interventions aimed at reducing ischemia-reperfusion injury.

Citing Articles

H NMR metabonomic analysis of serum and flap tissue on the effect of ginsenoside Rb1 on survival of random pattern skin flaps in rats.

Huang Y, Liu Y, Meng F, Wijaya W, Cao C Sci Rep. 2025; 15(1):7416.

PMID: 40033034 PMC: 11876603. DOI: 10.1038/s41598-025-91798-z.

Bionic nanovesicles sequentially treat flaps with different durations of ischemia by thrombolysis and prevention of ischemia-reperfusion injury.

Yang L, Liu Y, Tao C, Cao Z, Guo S, Wei Z Mater Today Bio. 2025; 31:101529.

PMID: 39990733 PMC: 11846944. DOI: 10.1016/j.mtbio.2025.101529.

Bibliometric analysis of skeletal muscle ischemia/reperfusion (I/R) research from 1986 to 2022.

Zhou M, Jia X, Liu H, Xue Y, Wang Y, Li Z Heliyon. 2024; 10(18):e37492.

PMID: 39309867 PMC: 11416534. DOI: 10.1016/j.heliyon.2024.e37492.

Effect of umbilical cord mesenchymal stem cell-derived mitochondrial transplantation on ischemia-reperfusion injury in a rat model.

Lee C, Khan G, Hyun D, Kim S, Park E Skin Res Technol. 2024; 30(9):e70022.

PMID: 39221632 PMC: 11367251. DOI: 10.1111/srt.70022.

Hypoxic mesenchymal stem cell-derived exosomes promote the survival of skin flaps after ischaemia-reperfusion injury via mTOR/ULK1/FUNDC1 pathways.

Deng C, Dong K, Liu Y, Chen K, Min C, Cao Z J Nanobiotechnology. 2023; 21(1):340.

PMID: 37735391 PMC: 10514998. DOI: 10.1186/s12951-023-02098-5.